Combined treatment of vitamin K(2) and angiotensin-converting enzyme inhibitor ameliorates hepatic dysplastic nodule in a patient with liver cirrhosis

Although it is well known that the hepatocellular carcinoma (HCC) is an ominous complication in patients with liver cirrhosis, there has been no approved drug to prevent the development of HCC to date. We previously reported that the combined treatment of vitamin K(2) (VK) and angiotensin-converting...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :World J Gastroenterol
Главные авторы: Yoshiji, Hitoshi, Noguchi, Ryuichi, Yamazaki, Masaharu, Ikenaka, Yasuhide, Sawai, Masayoshi, Ishikawa, Masatoshi, Kawaratani, Hideto, Mashitani, Tsuyoshi, Kitade, Mitsuteru, Kaji, Kosuke, Uemura, Masahito, Yamao, Junichi, Fujimoto, Masao, Mitoro, Akira, Toyohara, Masahisa, Yoshida, Motoyuki, Fukui, Hiroshi
Формат: Artigo
Язык:Inglês
Опубликовано: Baishideng Publishing Group Co., Limited 2007
Предметы:
Case Report
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4436616/
https://ncbi.nlm.nih.gov/pubmed/17589909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v13.i23.3259
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы